|
|
Blood, 15 December 2004, Vol. 104, No. 13, pp. 4080-4087.
Prepublished online as a Blood First Edition Paper on August 19, 2004; DOI 10.1182/blood-2004-03-1166.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Lysophosphatidic acid accelerates the development of human mast cells
Savita Bagga,
Kursteen S. Price,
Debby A. Lin,
Daniel S. Friend,
K. Frank Austen, and
Joshua A. Boyce
From the Departments of Medicine and Pediatrics, Harvard Medical School; Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital; and Partners Asthma Center, Boston, MA.
Mast cells (MCs) initiate immune responses from mucosal surfaces and perivascular spaces. Stem cell factor (SCF) regulates MC development and viability, but the role of innate serum factors in MC development is unexplored. Cultured cord blood-derived human MCs (hMCs) express mRNA transcripts for all 4 known receptors for lysophosphatidic acid (LPA), an abundant serum-associated lipid growth factor. In an SCF-dependent serum-free culture system, LPA (2.5-10 µM) increased the total number of hMCs by approximately 10-fold compared with cultures maintained in the absence of LPA under otherwise identical conditions. LPA was comitogenic with SCF but did not prolong MC survival. LPA-mediated proliferation was blocked by VPC-32179, a competitive antagonist of LPA1 and LPA3 receptors, and by pertussis toxin, and it was also attenuated by GW9662, a selective antagonist of peroxisome proliferator-activated receptor (PPAR)- . LPA accelerated the acquisition of hMC granules and increased Kit expression. hMCs derived in the presence of LPA were functional, as evidenced by their immunoglobulin E (IgE)-dependent histamine release and by their characteristic proliferative responses to interleukin-3 (IL-3), IL-4, and IL-9 in combination with SCF. Thus, LPA acts through LPA receptor and PPAR--dependent pathways to accelerate hMC proliferation and differentiation, and it modulates their phenotype without providing cytoprotection. LPA could facilitate MC hyperplasia in inflammation associated with either innate or adaptive immunity. (Blood. 2004; 104:4080-4087)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
X. Ye
Lysophospholipid signaling in the function and pathology of the reproductive system
Hum. Reprod. Update,
June 25, 2008;
(2008)
dmn023v2.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Paruchuri, Y. Jiang, C. Feng, S. A. Francis, J. Plutzky, and J. A. Boyce
Leukotriene E4 Activates Peroxisome Proliferator-activated Receptor {gamma} and Induces Prostaglandin D2 Generation by Human Mast Cells
J. Biol. Chem.,
June 13, 2008;
283(24):
16477 - 16487.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C.-P. Liu, Y.-C. Kuo, C.-C. Shen, M.-H. Wu, J.-F. Liao, Y.-L. Lin, C.-F. Chen, and W.-J. Tsai
(S)-Armepavine inhibits human peripheral blood mononuclear cell activation by regulating Itk and PLC{gamma} activation in a PI-3K-dependent manner
J. Leukoc. Biol.,
May 1, 2007;
81(5):
1276 - 1286.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-M. Chung, O.-N. Bae, K.-M. Lim, J.-Y. Noh, M.-Y. Lee, Y.-S. Jung, and J.-H. Chung
Lysophosphatidic Acid Induces Thrombogenic Activity Through Phosphatidylserine Exposure and Procoagulant Microvesicle Generation in Human Erythrocytes
Arterioscler. Thromb. Vasc. Biol.,
February 1, 2007;
27(2):
414 - 421.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Rahaman, R. W. Costello, K. E. Belmonte, S. S. Gendy, and M.-T. Walsh
Neutrophil Sphingosine 1-Phosphate and Lysophosphatidic Acid Receptors in Pneumonia
Am. J. Respir. Cell Mol. Biol.,
February 1, 2006;
34(2):
233 - 241.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Lin and J. A. Boyce
IL-4 Regulates MEK Expression Required for Lysophosphatidic Acid-Mediated Chemokine Generation by Human Mast Cells
J. Immunol.,
October 15, 2005;
175(8):
5430 - 5438.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
